Vandetanib alters the tumoricidal capacity of human breast cancer stem cells via inhibiting vasculogenic capacity

CONCLUSION: Vandetanib suppressed vasculogenic mimicry (VM) networking through blunting stemness properties, coincided with suppression of VE-cadherin in CSCs.PMID:37736340 | PMC:PMC10509738 | DOI:10.34172/bi.2022.24208

Source: BioImpacts - September 22, 2023 Category: Research Authors: Sanya Haiaty Mohammad-Reza Rashidi Maryam Akbarzadeh Ahad Bazmany Mostafa Mostafazadeh Saba Nikanfar Roya Shabkhizan Rostam Rezaeian Reza Rahbarghazi Mohammad Nouri Source Type: research